For Immediate Release
For additional information, contact:
Paul J. Carbone, Co-Director
Baird Private Equity
312-609-4911
pcarbone@rwbaird.com
Angela Pittman, Public Relations Coordinator
Robert W. Baird & Co.
414-298-1902
apittman@rwbaird.com
MILWAUKEE, February 9, 2004 – Baird Venture Partners (BVP), which recently closed on more than $100 million in committed capital, has added Peter K. Shagory as a Principal in its Chicago office.
“We’re excited to have Pete join our venture group,” said Paul J. Carbone, Co-Director of Baird Private Equity and Managing Partner for BVP. “He is an exceptional talent and will add tremendous value to our team.”
Shagory will help lead BVP’s activities in the Healthcare/Life Sciences sector and expand the group’s efforts in biotechnology and medical devices. Prior to joining BVP, he served as vice president at Vector Fund Management L.P., where he managed venture investments in life science companies in the biopharmaceutical, medical device and healthcare IT sectors. Prior to joining Vector Fund Management, Shagory was an investment banker at J.P. Morgan & Co. and an analyst in the private equity and corporate finance groups of Banc One Capital Corporation. He received a BS in business administration from Miami University (Oxford, Ohio), and an MBA from the Amos Tuck School at Dartmouth College.
Over the past several years, Robert W. Baird & Co. has substantially increased its firm-wide commitment to the healthcare and life sciences sector with personnel additions across investment banking, equity research and private equity. Over the last decade, Baird has made private equity investments in a number of healthcare and life sciences companies in the U.S. and Europe including: Centerre Healthcare Corporation, Corin Group plc, NetRegulus, Inc., NimbleGen Systems, Inc., Packard BioScience Company, PharMEDium Healthcare Corporation, Promega Corporation, TomoTherapy, Inc. and Ultralase Ltd.
###
About Baird Private Equity
With more than 40 professionals in the United States and Europe, Baird’s global private equity business has raised and managed $1 billion in capital. Baird Capital Partners (BCP) provides late-stage growth capital or change-of-control capital to U.S.-based, middle- market companies in the areas of Business Services, Industrial Products and Technology,
Communications, Consumer and Healthcare/Life Sciences. Baird Venture Partners (BVP) makes venture capital investments in early- to late-stage high-growth companies in three industry sectors: Business Services, Technology and Healthcare/Life Sciences. Granville Baird Capital Partners (GBCP) is a long-established private equity manager targeting mid-market growth companies principally in the UK and Germany with a focus on the Business Services, Healthcare, Industrial Products & Services and Technology sectors. The group’s investments are supported by Baird’s full range of financial advice, operating expertise and industry research, providing a unique full-service approach to the entire private equity investment process. For more information, please visit Baird’s Private Equity website at www.bairdprivateequity.com.
About Baird
Baird, established in 1919, is an international wealth management, investment banking, asset management and private equity firm with offices in the United States, United Kingdom and Germany. Baird’s principal operating subsidiaries are Robert W. Baird & Co. in the United States and Robert W. Baird Group Ltd. in Europe.
Regularly recognized as a great place to work, in 2004 Robert W. Baird & Co. was included for the first time on FORTUNE magazine’s annual list of the “100 Best Companies to Work For.” Robert W. Baird & Co. is a member of the New York Stock Exchange and other principal exchanges and the Securities Investor Protection Corporation (SIPC). Robert W. Baird Ltd., a member of the London Stock Exchange, and Granville Baird Capital Partners Ltd. are authorized and regulated in the United Kingdom by the Financial Services Authority. Baird is part of the Northwestern Mutual family of companies. For more information, please visit Baird’s Web site at www.rwbaird.com.
